Audere’s HealthPulse@home COVID-19 Test Gets FDA’s Emergency Use Authorization

The FDA has issued an Emergency Use Authorization to Seattle, Wash.-based Audere for its HealthPulse@home COVID-19 test collection kit.

Nasal swab samples collected at home using the kit are shipped at ambient temperature for testing in a laboratory.

If present in the sample, RNA from the SARS-CoV-2 virus that causes COVID-19 infection is detected using an approved molecular diagnostic test.